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Abstract Protein P19 encoded by the conjugative resistance
plasmid R1, is essential for efficient conjugative DNA transfer
and infection by the pilus-specific RNA phage R17. Based on
sequence homologies P19 belongs to a family of lysozyme-like
virulence factors which are found in type III and type IV
secretion systems. In this report we describe the processing and
subcellular localization of P19. Pulse-chase experiments were
used to demonstrate the processing of P19 by the signal peptidase
I of Escherichia coli. Translocation of P19 across the inner
membrane was shown by gene 19-phoA fusions. Cell fractiona-
tion studies of P19 expressing cells showed the presence of P19 in
the membrane compartment. P19 was solubilized with the
detergent Sarkosyl indicating an inner membrane localization.
Using sucrose density gradient centrifugation to separate inner
and outer membranes, P19 was found in both membrane
fractions. Taken together, our data suggest that mature P19 is
a periplasmic protein which may be attached to the proposed
membrane-spanning DNA transport complex.
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1. Introduction
In order to cope with the high osmotic pressure most eu-
bacteria have to maintain a rigid cell wall that is composed of
a unique biopolymer called murein or peptidoglycan which
surrounds the whole cell. In Gram-negative bacteria peptido-
glycan comprises a single macromolecule which is embedded
in the periplasm between the outer and inner membrane. Dis-
ruption of the peptidoglycan or the unbalanced action of
murein-synthesizing and -degrading enzymes (for a recent re-
view see [1]) is deleterious for the cell and leads to lysis and
cell death. The successful treatment of infectious diseases by
the use of L-lactam antibiotics is based on the above men-
tioned process. One of the glycan strand-degrading enzymes in
Escherichia coli is the soluble lytic transglycosylase Slt70 [2].
Slt70 is an exomuramidase cleaving the L-1,4-glycosidic bond
and has been crystallized recently [3]. Sequence database
searches using the conserved residues present in the catalytic
domain of the enzyme [4] revealed that the lytic transglycosy-
lase motif is present in a large family of proteins [5^9]. Intri-
guingly, some members of this growing protein family are
encoded by type III and type IV macromolecular transport
systems, a ¢nding implying that these systems utilize their own
specialized lytic transglycosylases to facilitate e⁄cient trans-
envelope transport of DNA and/or protein substrates.
P19 encoded by gene 19 of the F-like conjugative resistance
plasmid R1 is a member of lysozyme-like virulence factors
with the lytic transglycosylase motif [6^9]. Gene 19 is located
next to the origin of conjugal DNA transfer, oriT of R1, and
encodes a polypeptide of 169 amino acids (SwissProt: P17738)
[10]. Expression of gene 19 is tightly controlled post-transcrip-
tionally by RNase III [11]. Recent experiments demonstrated
that protein P19 is essential for e⁄cient conjugal DNA trans-
fer and RNA phage infection [6]. The transmission of ssDNA
during conjugation is believed to be achieved by a membrane-
spanning transport complex comprising several transfer pro-
teins. However, the nature and the composition of the com-
plex are largely unknown [12]. Due to the sequence homolo-
gies of P19 to the lytic transglycosylase we hypothesized that
P19 exhibits its function at the murein sacculus and might
associate with the envelope-spanning transport complex to
facilitate its correct assembly by catalyzing a controlled local-
ized opening in the peptidoglycan. In order to test the validity
of this hypothesis we investigated the subcellular localization
and processing of P19. The results of these investigations are
presented here.
2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
E. coli K38 [pGP1-2] cells were used for protein expression experi-
ments [13]. E. coli PN1 was used for random integration of TnphoA
and E. coli CC118 was used for alkaline phosphatase assays [14].
Plasmids pCS217 and pCK217 were described previously [11]. The
construction of the recombinant plasmids pCK217ns and pCKBlaP19
is described below. E. coli cells were grown in 2UTY medium (16 g of
tryptone, 10 g of yeast extract, 5 g of NaCl per liter) or in minimal
medium M9 (6 g Na2HPO4, 3 g K2HPO4, 1 g NH4Cl, 0.5 g NaCl per
liter; 1 mM MgSO4, 0.4% (w/v) glucose and 100 Wg ml31 thiamine).
Antibiotics, when needed, were added at the following concentrations:
epicillin (dihydroampicillin), 100 Wg ml31 ; tetracycline, 15 Wg ml31 ;
kanamycin, 40 Wg ml31.
2.2. Enzymes, chemicals and oligonucleotides
Restriction endonucleases and other enzymes used for standard
cloning and DNA modi¢cation procedures were purchased from
Roche Diagnostics. The thermostable DNA polymerases DynaZyme
and Expand1 High Fidelity PCR System were purchased from Finn-
zymes and Roche Diagnostics, respectively. Radiochemicals were pur-
chased from Amersham International or from Dupont, NEN Re-
search Products. Oligonucleotides were purchased from the Vienna
Biocenter or MWG Biotech.
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2.3. DNA manipulations
Recombinant DNA techniques were performed according to
[15,16], or the manufacturers’ protocols.
2.4. Site-speci¢c mutagenesis
The signal sequence of protein P19 was removed by oligonucleotide
directed deletion mutagenesis as described previously [17]. Oligonu-
cleotide Gen19dlp, 5P-CCAGAGGTGGAAAAATGTGCTTTGATC-
TTGCAGG-3P, and the plasmid pCK217 with the wild-type gene 19
were used to create an in-frame deletion of amino acids 2^21 of P19.
The resulting plasmid, pCK217ns, was sequenced to con¢rm the mu-
tation. The replacement of the signal sequence of protein P19 by
residues 1^27 of TEM-1L-lactamase was carried out by cloning a
110 bp PCR fragment from pBluescript SK+ £anked by HindIII/
Sau3a restriction sites into the HindIII/BglII restricted plasmid
pCK217. The PCR fragments were produced by using the following
oligonucleotides: BLAPRIMER1, 5P-TTTAAGCTTGAAAAAGGA-
AGAGTATGAG-3P and BLAPRIMER2, 5P-TTTGATCGTTTCTG-
GGTGAGCAAAAAC-3P. The resulting recombinant plasmid was
designated pCKBlaP19 and its sequence was veri¢ed. The gene 19-
phoA fusions were constructed by random integration of TnphoA [14].
The recombinant plasmid pCK217 was transformed into the trans-
poson donor strain E. coli PN1. Following the in vivo transposition
event, plasmid DNA was isolated and digested with HindIII and DraI
for a ¢rst estimation of the position of the TnphoA insertion. Auto-
mated DNA sequencing was then used to determine the exact TnphoA
integration site. Plasmid DNA was used for the transformation of
competent CC118 cells and alkaline phosphatase activity was meas-
ured according to [18].
2.5. Protein expression
Protein expression experiments were performed as described previ-
ously [19]. E. coli K38 [pGP1-2] cells harboring the P19, P19ns or
BlaP19 expressing plasmids pCK217, pCK217ns or pCKBlaP19, re-
spectively, were used for pulse-chase experiments. Proteins were pulse-
labeled for 45 s with [35S]methionine/cysteine and chased with an
excess of cold methionine/cysteine (¢nal concentration of 0.1%). After
the addition of the chase 120 Wl aliquots of cell suspension were taken
at the times indicated. Ice-cold trichloroacetic acid (10% ¢nal concen-
tration) was added and the cells were collected by centrifugation at
17 400Ug for 10 min at 4‡C. The samples were resuspended in SDS^
PAGE sample bu¡er (60 mM Tris^hydrochloride, pH 6.8, 1% SDS,
1% 2-mercaptoethanol, 10% glycerol, and 0.01% bromophenol blue)
and boiled for 10 min. The extracted proteins were separated by 15%
SDS^PAGE and visualized afterwards using a phosphorimager. The
radioactivity in speci¢c bands was quantitated using the ImageQuant
software (Molecular Dynamics). As a control, the signal peptidase I
inhibitor 2-phenylethanol [20,21] was added to a ¢nal concentration
of 0.3%.
2.6. Cellular fractionation
For all fractionation studies protein P19 was expressed in E. coli
K38 harboring plasmid pCS217 (wild-type) or pCS260 (negative con-
trol) as described earlier [11]. After labeling the proteins with
[35S]methionine, cells were harvested, broken by sonication and the
cell debris was removed by centrifugation at 3000Ug for 15 min. The
membrane fraction was collected by centrifugation at 48 000Ug for 1 h.
The pellet was treated with the ionic detergent Sarkosyl (N-lauroyl
sarcosinate) to solubilize the inner membrane proteins as described by
Filip [22]. On the other hand inner and outer membranes were sepa-
rated according to their buoyant densities by centrifugation through
layers of 53% and 70% sucrose (w/v), containing 3 mM EDTA, at
25 000 rpm for 16 h in a swinging bucket rotor at 4‡C. After collecting
the membrane fractions, a puri¢cation step with Sarkosyl was added.
Proteins in various fractions of the sucrose gradient were resuspended
in SDS^PAGE sample bu¡er, boiled for 10 min, separated by 15%
SDS^PAGE and visualized by autoradiography. To enhance the in-
tensity of autoradiographic images, gels were treated with dimethyl-
sulfoxide/2,5-diphenyloxazole (DMSO/PPO) [23], dried and exposed
to X-ray ¢lms.
3. Results and discussion
3.1. P19 and P19 fusion constructions
Using the signal sequence prediction tool SignalP [24] anal-
ysis of the P19 sequence revealed a typical prokaryotic signal
sequence with a predicted cleavage site between residues A19
and T20. The proposed cleavage and processing of the P19
preprotein (P19p) to the mature form of P19 (P19m) is sche-
matically illustrated in Fig. 1. To investigate the physiological
relevance of the signal sequence the N-terminal part of P19
was removed leading to a construct named P19ns. In order to
investigate the export of P19 by a known export sequence, the
P19 signal sequence was replaced by residues 1^27 of the
signal sequence of TEM-1L-lactamase. The fusion protein
generated from this construction was designated BlaP19. Its
proposed processing is shown in Fig. 1 together with the L-
lactamase signal sequence cleavage site between residues A23
and H24 [25].
3.2. Processing of P19 and BlaP19
To evaluate the processing of P19 and BlaP19 pulse-chase
experiments were performed. Within the period of observation
the translation product, P19p, is converted to the mature
form, P19m (Fig. 2). However, during this time the larger
preprotein form of P19 never completely disappeared. Equiv-
alent amounts of P19p and P19m were observed approxi-
mately 340 s after addition of the chase (Fig. 2B). We attrib-
ute the incomplete processing of P19 in the pulse-chase
experiment to the rapid formation of inclusion bodies in the
cytoplasm that are readily formed when P19 or P19 deriva-
tives are over-expressed in E. coli. It is reasonable to assume
Fig. 1. Schematic representation of gene 19 polypeptides. P19p is
the immediate translation product of gene 19 possessing a typical
signal sequence located at its N-terminus. The wild-type protein has
a calculated molecular weight of 19.3 kDa (SwissProt: P17738). Sig-
nal peptidase I cleavage (open arrow) between alanine (A) at posi-
tion 19 and threonine (T) at position 20 produces the mature pro-
tein P19m consisting of 150 amino acids (17.0 kDa). P19ns is a
modi¢ed protein without signal sequence. The calculated molecular
weight of P19ns is 16.8 kDa. In BlaP19 the ¢rst 15 amino acids of
protein P19 are replaced by the amino-terminus of TEM-1L-lactam-
ase. 27 amino acids from TEM-1L-lactamase were fused to 154 C-
terminal amino acids of protein P19 to give a preprotein with 181
amino acids (BlaP19p). The result of signal peptidase I cleavage
(open arrow) between alanine (A) at position 23 and histidine (H)
at position 24 gives rise to the mature protein BlaP19m consisting
of 158 amino acids.
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that P19 present in these insoluble aggregates is not accessible
for transport and processing. The processing of protein P19
was completely inhibited by the presence of 2-phenylethanol.
Because of the presence of a cysteine residue near the pro-
posed cleavage site of P19, we also investigated whether a
prolipoprotein-speci¢c signal peptidase (signal peptidase II)
is involved in the processing of P19. Since the processing of
P19p to P19m also occurred in the presence of the speci¢c
signal peptidase II inhibitor globomycin [26], this possibility
could be excluded (data not shown). In the case of P19ns,
only one protein band corresponding to the expected molec-
ular weight of 16.8 kDa was detected. The failure of P19ns to
be processed suggests that it is not transported across the
inner membrane. In vivo analysis of the N-terminally trun-
cated polypeptide indicated that the presence of a signal se-
quence in P19 is essential for the biological activity. It can be,
however, replaced by the L-lactamase signal sequence without
a loss of function of P19 [27]. As shown in Fig. 3, the con-
version of the unprocessed form of the hybrid protein
BlaP19p to mature BlaP19m occurred more rapidly than in
the case of the wild-type P19 protein. 110 s after the addition
of the chase 50% of the original preprotein was processed
(Fig. 3B). As in the case of wild-type P19 processing of
BlaP19p was completely blocked by the addition of 2-phenyl-
ethanol indicating that the processing of the hybrid protein is
dependent on the activity of signal peptidase I. This result also
showed that the signal sequence cleavage site of P19 is recog-
nized less e⁄ciently by the preprotein processing signal pepti-
dase I of E. coli than that of the arti¢cially created BlaP19
hybrid protein. The size of the BlaP19m protein as estimated
from the SDS^PAGE shown in Fig. 3 suggests that BlaP19p is
cleaved at the position of the signal sequence cleavage site
which has been determined for L-lactamase [25].
3.3. Gene 19-phoA fusions
Proteins equipped with a signal sequence are either destined
for export or for a membrane location [28]. A periplasmic
location in close association with other membrane anchored
proteins would be consistent with the postulated role of P19
acting as a muramidase. To corroborate this hypothesis a
random fusion of phoA to gene 19 was used as a sensor for
the subcellular localization of P19. Generation of a fusion
protein that exhibits alkaline phosphatase activity using this
approach can only occur when the portion derived from the
target protein possesses su⁄cient signals to drive localization
of the catalytic domain of alkaline phosphatase to the peri-
plasm. In a transposon mediated fusion approach three di¡er-
ent constructions were obtained. In one case, the transposon
inserted outside of gene 19. In the second construct PhoA was
fused to amino acid N55 of P19. The fusion position in the
third construct was at amino acid Y134 of P19. The enzymatic
activity of alkaline phosphatase expressed from the three dif-
ferent recombinant plasmids were 0.2 U, 1738 U and 1531 U,
respectively. These values indicate unambiguously that the
Fig. 2. Processing of protein P19wt. E. coli K38 [pGP1-2] cells ex-
pressing the indicated proteins were pulse-labeled for 45 s with
[35S]methionine/cysteine in the absence (3) or in the presence (+) of
2-phenylethanol (PEA) and chased with an excess of unlabeled
methionine/cysteine. A: Labeled proteins were separated by SDS^
PAGE and visualized using a phosphorimager. The duration of the
chase time in seconds is indicated below each lane. P19wt, wild-type
P19; P19ns, P19 without its signal sequence. The upper arrow indi-
cates the position of the preprotein, P19p, the lower arrow that of
the mature product, P19m. B: The percentage of the total radioac-
tivity present in either precursor (squares) or mature (diamonds)
form as a function of chase time is presented graphically.
Fig. 3. Processing of the hybrid protein BlaP19. The pulse-chase ex-
periment was performed as described in the legend to Fig. 2. A: A
phosphorimage of an SDS^PAGE is shown. BlaP19, signal sequence
of L-lactamase fused to P19; control, vector control. The upper ar-
row indicates the position of the preprotein, BlaP19p, the lower ar-
row that of the mature product, BlaP19m. B: The percentage of the
total radioactivity present in either precursor (squares) or mature
(diamonds) form as a function of chase time is presented graphi-
cally.
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¢rst 55 amino acids of P19 are su⁄cient to convey the hybrid
protein to the periplasm. It has been shown by analogous
experiments with VirB1 and IpgF, respectively, that these
P19 homologues are also transported to the periplasm
[29,30]. Together with the pulse-chase experiments, the data
suggest that P19 is transported across the inner membrane by
the utilization of a cleavable signal sequence. The results also
imply that P19m is released into the periplasm.
3.4. Cell fractionation studies
Membrane separation was performed in two ways, namely
by dissolution with the ionic detergent Sarkosyl and by su-
crose gradient centrifugation. As expected both P19p and
P19m were found to be present in the whole cell lysate (Fig.
4, lane A). The mature form P19m was also readily detectable
in the Sarkosyl soluble fraction as well as a weak band cor-
responding to P19p which was only visible on the original
autoradiogram (lane D). In the cytoplasm (lane B) and Sar-
kosyl insoluble fraction (lane C) no P19 protein could be
detected. To con¢rm this ¢nding inner and outer membranes
were resolved according to their buoyant densities by sucrose
gradient centrifugation. As shown in Fig. 5, both forms of the
protein were found in the outer and inner membrane fractions
(lanes D and G), although marker proteins, such as outer
membrane proteins, were clearly separated (data not shown).
When the fractions were subsequently treated with Sarkosyl
the protein was consistently resolved in the soluble fraction
(Fig. 5, lane H). These results suggested the intriguing possi-
bility that the presence of the protein in both membrane frac-
tions of the sucrose gradient is due to a membrane-spanning
protein complex to which both forms of P19 (P19m and P19p)
are attached. This complex could be composed of the enve-
lope-spanning DNA transport proteins produced by the Hfr
strain K38 which was used as a host. It has been shown that
the mating pair formation (Mpf) components of the RP4
plasmid fractionated by density £otation gradients of mem-
branes revealed an additional membrane fraction with the
density close to that of the outer membrane [12]. The inter-
pretation of these results was that the Mpf of RP4 connects
the cytoplasm and the outer membrane. Similarly to our ob-
servations, the P19 homologous VirB1 protein from the Ti
plasmid of Agrobacterium tumefaciens was more prominent
in the outer membrane fraction of a sucrose gradient. Like
P19, VirB1 was found to be Sarkosyl soluble and the fractio-
nation behavior was attributed to association of VirB1 to a
transport channel that spans both membranes [31].
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